Clene is a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease with potential first-in-class nanotherapeutics to treat energetic failure, an underlying driver of many neurological diseases. The Company’s lead drug candidate, CNM-Au8, is an oral suspension of gold nanocrystals that drive critical cellular energetic metabolism in the central nervous system (CNS). CNM-Au8 increases energy production and utilization to accelerate neurorepair and improve neuroprotection. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses.
Location: United States, Utah, Salt Lake City
Employees: 51-200
Total raised: $42.5M
Founded date: 2013
Investors 2
| Date | Name | Website |
| - | SV Investm... | svinvest.c... |
| - | SymBiosis | symbiosis.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.08.2020 | Series D | $42.5M | - |
Mentions in press and media 8
| Date | Title | Description | Source |
| 13.03.2024 | Clene Reports Full Year 2023 Financial Results and Recent Op... | - | globenewsw... |
| 07.03.2024 | Clene to Present at the 36th Annual ROTH Conference | - | globenewsw... |
| 04.10.2022 | ROTH Capital Partners to Host Inaugural Healthcare Opportuni... | Event to feature company presentations and one-on-one meetings between institutional investors and s... | einpresswi... |
| 24.05.2021 | CLENE INC. Clene : Announces Plan to Expand its Manufacturi... | Clene Announces Plan to Expand its Manufacturing Capacity of CNM-Au8, Closing of Up to $30 Million D... | marketscre... |
| 24.05.2021 | CLENE INC. Clene : Announces Plan to Expand its Manufacturi... | SALT LAKE CITY, May 24, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiar... | marketscre... |
| 18.11.2020 | Maryland is eyeing these 20 startups for future success | Tuesday was National Entrepreneur’s Day, and Gov. Larry Hogan of Maryland used the occasion to annou... | technical.... |
| 28.08.2020 | Clene Nanomedicine Raises $42.5M in Series D Funding | Clene Nanomedicine, Inc., a Salt Lake City, UT-based clinical-stage biopharmaceutical company focuse... | finsmes.co... |
| 26.08.2020 | Clene Nanomedicine Raises $42.5M Series D Financing | Clene Nanomedicine, Inc., a Salt Lake City, UT-based clinical-stage biopharmaceutical company, secur... | finsmes.co... |